Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for CEBPA
Z-value: 2.32
Motif logo
Transcription factors associated with CEBPA
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
CEBPA
|
ENSG00000245848.2 | CCAAT enhancer binding protein alpha |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| CEBPA | hg19_v2_chr19_-_33793430_33793470 | -0.37 | 1.1e-01 | Click! |
Activity profile of CEBPA motif
Sorted Z-values of CEBPA motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr9_+_130911723 | 13.85 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
| chr20_-_43883197 | 12.93 |
ENST00000338380.2
|
SLPI
|
secretory leukocyte peptidase inhibitor |
| chr9_+_130911770 | 12.42 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
| chr12_-_10007448 | 9.96 |
ENST00000538152.1
|
CLEC2B
|
C-type lectin domain family 2, member B |
| chr18_-_61329118 | 9.95 |
ENST00000332821.8
ENST00000283752.5 |
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
| chr11_-_102668879 | 9.87 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
| chr11_-_18270182 | 8.28 |
ENST00000528349.1
ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2
|
serum amyloid A2 |
| chr11_+_18287801 | 8.18 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
| chr11_+_18287721 | 7.80 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
| chr2_-_113594279 | 7.40 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
| chr12_-_123187890 | 6.95 |
ENST00000328880.5
|
HCAR2
|
hydroxycarboxylic acid receptor 2 |
| chr18_-_61311485 | 6.48 |
ENST00000436264.1
ENST00000356424.6 ENST00000341074.5 |
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
| chr12_-_123201337 | 6.15 |
ENST00000528880.2
|
HCAR3
|
hydroxycarboxylic acid receptor 3 |
| chr11_-_104905840 | 6.12 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
| chr1_+_196621002 | 5.98 |
ENST00000367429.4
ENST00000439155.2 |
CFH
|
complement factor H |
| chr18_+_61554932 | 5.96 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
| chr6_+_31895467 | 5.59 |
ENST00000556679.1
ENST00000456570.1 |
CFB
CFB
|
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
| chr11_-_104972158 | 5.37 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
| chr6_+_31895480 | 5.01 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
C2
CFB
|
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
| chr1_+_196621156 | 4.87 |
ENST00000359637.2
|
CFH
|
complement factor H |
| chr11_-_104916034 | 4.41 |
ENST00000528513.1
ENST00000375706.2 ENST00000375704.3 |
CARD16
|
caspase recruitment domain family, member 16 |
| chr4_-_119274121 | 4.35 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
| chr6_-_113953705 | 4.32 |
ENST00000452675.1
|
RP11-367G18.1
|
RP11-367G18.1 |
| chr1_+_152486950 | 4.07 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
| chr19_-_6720686 | 4.00 |
ENST00000245907.6
|
C3
|
complement component 3 |
| chr11_-_18258342 | 3.95 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
| chr14_+_95078714 | 3.88 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
| chr11_+_123986069 | 3.82 |
ENST00000456829.2
ENST00000361352.5 ENST00000449321.1 ENST00000392748.1 ENST00000360334.4 ENST00000392744.4 |
VWA5A
|
von Willebrand factor A domain containing 5A |
| chr11_-_59633951 | 3.79 |
ENST00000257264.3
|
TCN1
|
transcobalamin I (vitamin B12 binding protein, R binder family) |
| chr19_-_36004543 | 3.69 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
| chr9_+_6215799 | 3.52 |
ENST00000417746.2
ENST00000456383.2 |
IL33
|
interleukin 33 |
| chr13_+_78109804 | 3.43 |
ENST00000535157.1
|
SCEL
|
sciellin |
| chr1_-_153029980 | 3.40 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
| chr18_+_61144160 | 3.38 |
ENST00000489441.1
ENST00000424602.1 |
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
| chr5_+_125758865 | 3.38 |
ENST00000542322.1
ENST00000544396.1 |
GRAMD3
|
GRAM domain containing 3 |
| chr2_+_228678550 | 3.31 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
| chr18_-_28622774 | 3.27 |
ENST00000434452.1
|
DSC3
|
desmocollin 3 |
| chr18_-_28622699 | 3.27 |
ENST00000360428.4
|
DSC3
|
desmocollin 3 |
| chr5_+_125758813 | 3.24 |
ENST00000285689.3
ENST00000515200.1 |
GRAMD3
|
GRAM domain containing 3 |
| chr13_+_78109884 | 3.23 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
| chr4_+_74606223 | 3.21 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
| chr7_+_129932974 | 3.13 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
| chr17_+_1665345 | 3.07 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr19_-_4540486 | 3.05 |
ENST00000306390.6
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1 |
| chr11_+_117947782 | 3.04 |
ENST00000522307.1
ENST00000523251.1 ENST00000437212.3 ENST00000522824.1 ENST00000522151.1 |
TMPRSS4
|
transmembrane protease, serine 4 |
| chr10_+_118187379 | 2.94 |
ENST00000369230.3
|
PNLIPRP3
|
pancreatic lipase-related protein 3 |
| chr3_+_118892411 | 2.91 |
ENST00000479520.1
ENST00000494855.1 |
UPK1B
|
uroplakin 1B |
| chr19_-_6670128 | 2.89 |
ENST00000245912.3
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14 |
| chr2_+_223289208 | 2.88 |
ENST00000321276.7
|
SGPP2
|
sphingosine-1-phosphate phosphatase 2 |
| chr4_-_10023095 | 2.82 |
ENST00000264784.3
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
| chr19_-_54676846 | 2.78 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
| chr19_-_35992780 | 2.78 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
| chr6_-_41130914 | 2.75 |
ENST00000373113.3
ENST00000338469.3 |
TREM2
|
triggering receptor expressed on myeloid cells 2 |
| chr1_-_89531041 | 2.73 |
ENST00000370473.4
|
GBP1
|
guanylate binding protein 1, interferon-inducible |
| chr14_-_81893734 | 2.66 |
ENST00000555447.1
|
STON2
|
stonin 2 |
| chr19_-_54676884 | 2.60 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
| chr5_+_49962772 | 2.55 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr3_+_118905564 | 2.52 |
ENST00000460625.1
|
UPK1B
|
uroplakin 1B |
| chr3_+_118892362 | 2.44 |
ENST00000497685.1
ENST00000264234.3 |
UPK1B
|
uroplakin 1B |
| chr6_+_106988986 | 2.44 |
ENST00000457437.1
ENST00000535438.1 |
AIM1
|
absent in melanoma 1 |
| chr1_-_153348067 | 2.40 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
| chr15_-_23932437 | 2.32 |
ENST00000331837.4
|
NDN
|
necdin, melanoma antigen (MAGE) family member |
| chr17_+_1665253 | 2.31 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr19_-_36019123 | 2.31 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
| chr8_+_97597148 | 2.30 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
| chr11_-_119187826 | 2.21 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
| chr6_-_41130841 | 2.20 |
ENST00000373122.4
|
TREM2
|
triggering receptor expressed on myeloid cells 2 |
| chr4_+_186347388 | 2.19 |
ENST00000511138.1
ENST00000511581.1 |
C4orf47
|
chromosome 4 open reading frame 47 |
| chr10_-_45474237 | 2.18 |
ENST00000448778.1
ENST00000298295.3 |
C10orf10
|
chromosome 10 open reading frame 10 |
| chr8_+_74271144 | 2.11 |
ENST00000519134.1
ENST00000518355.1 |
RP11-434I12.3
|
RP11-434I12.3 |
| chr17_-_76124711 | 2.11 |
ENST00000306591.7
ENST00000590602.1 |
TMC6
|
transmembrane channel-like 6 |
| chr4_-_90756769 | 2.07 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr18_-_68004529 | 1.95 |
ENST00000578633.1
|
RP11-484N16.1
|
RP11-484N16.1 |
| chr1_-_153321301 | 1.92 |
ENST00000368739.3
|
PGLYRP4
|
peptidoglycan recognition protein 4 |
| chr5_-_39219641 | 1.90 |
ENST00000509072.1
ENST00000504542.1 ENST00000505428.1 ENST00000506557.1 |
FYB
|
FYN binding protein |
| chr2_-_31440377 | 1.86 |
ENST00000444918.2
ENST00000403897.3 |
CAPN14
|
calpain 14 |
| chr5_+_49963239 | 1.86 |
ENST00000505554.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr12_-_86230315 | 1.77 |
ENST00000361228.3
|
RASSF9
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
| chr3_+_40498783 | 1.77 |
ENST00000338970.6
ENST00000396203.2 ENST00000416518.1 |
RPL14
|
ribosomal protein L14 |
| chr6_+_30848557 | 1.76 |
ENST00000460944.2
ENST00000324771.8 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr3_+_10857885 | 1.75 |
ENST00000254488.2
ENST00000454147.1 |
SLC6A11
|
solute carrier family 6 (neurotransmitter transporter), member 11 |
| chr4_+_71384300 | 1.75 |
ENST00000504451.1
|
AMTN
|
amelotin |
| chr16_+_82090028 | 1.66 |
ENST00000568090.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
| chr16_+_8814563 | 1.64 |
ENST00000425191.2
ENST00000569156.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr5_+_125759140 | 1.64 |
ENST00000543198.1
|
GRAMD3
|
GRAM domain containing 3 |
| chr5_+_36608422 | 1.62 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr19_+_50084561 | 1.62 |
ENST00000246794.5
|
PRRG2
|
proline rich Gla (G-carboxyglutamic acid) 2 |
| chr7_-_92777606 | 1.60 |
ENST00000437805.1
ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L
|
sterile alpha motif domain containing 9-like |
| chr22_+_46481861 | 1.58 |
ENST00000360737.3
|
FLJ27365
|
hsa-mir-4763 |
| chr5_-_121413974 | 1.57 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
| chr20_+_12989596 | 1.57 |
ENST00000434210.1
ENST00000399002.2 |
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
| chr3_-_148939835 | 1.54 |
ENST00000264613.6
|
CP
|
ceruloplasmin (ferroxidase) |
| chr17_-_76124812 | 1.54 |
ENST00000592063.1
ENST00000589271.1 ENST00000322933.4 ENST00000589553.1 |
TMC6
|
transmembrane channel-like 6 |
| chr4_-_153274078 | 1.54 |
ENST00000263981.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
| chr6_+_30457244 | 1.53 |
ENST00000376630.4
|
HLA-E
|
major histocompatibility complex, class I, E |
| chr6_-_26199499 | 1.52 |
ENST00000377831.5
|
HIST1H3D
|
histone cluster 1, H3d |
| chr5_-_180229833 | 1.47 |
ENST00000307826.4
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr2_+_71693812 | 1.45 |
ENST00000409651.1
ENST00000394120.2 ENST00000409744.1 ENST00000409366.1 ENST00000410020.3 ENST00000410041.1 |
DYSF
|
dysferlin |
| chr3_-_107777208 | 1.45 |
ENST00000398258.3
|
CD47
|
CD47 molecule |
| chr12_+_69742121 | 1.42 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
| chr4_+_71384257 | 1.42 |
ENST00000339336.4
|
AMTN
|
amelotin |
| chr17_-_33760269 | 1.41 |
ENST00000452764.3
|
SLFN12
|
schlafen family member 12 |
| chr3_-_66551397 | 1.41 |
ENST00000383703.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
| chr14_+_72064945 | 1.38 |
ENST00000537413.1
|
SIPA1L1
|
signal-induced proliferation-associated 1 like 1 |
| chr6_+_29910301 | 1.37 |
ENST00000376809.5
ENST00000376802.2 |
HLA-A
|
major histocompatibility complex, class I, A |
| chr5_-_131630931 | 1.37 |
ENST00000431054.1
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
| chr1_+_12524965 | 1.36 |
ENST00000471923.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
| chr2_-_152382500 | 1.36 |
ENST00000434685.1
|
NEB
|
nebulin |
| chr1_+_117544366 | 1.35 |
ENST00000256652.4
ENST00000369470.1 |
CD101
|
CD101 molecule |
| chr8_+_145064215 | 1.35 |
ENST00000313269.5
|
GRINA
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
| chr3_-_49726486 | 1.35 |
ENST00000449682.2
|
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
| chr3_-_66551351 | 1.34 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
| chr2_+_220306745 | 1.33 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
| chr1_+_107682629 | 1.33 |
ENST00000370074.4
ENST00000370073.2 ENST00000370071.2 ENST00000542803.1 ENST00000370061.3 ENST00000370072.3 ENST00000370070.2 |
NTNG1
|
netrin G1 |
| chr4_-_185747188 | 1.33 |
ENST00000507295.1
ENST00000504900.1 ENST00000281455.2 ENST00000454703.2 |
ACSL1
|
acyl-CoA synthetase long-chain family member 1 |
| chr6_-_26199471 | 1.33 |
ENST00000341023.1
|
HIST1H2AD
|
histone cluster 1, H2ad |
| chr4_-_87028478 | 1.32 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr6_-_133055815 | 1.32 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
| chr3_-_18487057 | 1.31 |
ENST00000415069.1
|
SATB1
|
SATB homeobox 1 |
| chr3_-_143567262 | 1.31 |
ENST00000474151.1
ENST00000316549.6 |
SLC9A9
|
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 |
| chr17_-_38859996 | 1.30 |
ENST00000264651.2
|
KRT24
|
keratin 24 |
| chr10_-_75676400 | 1.30 |
ENST00000412307.2
|
C10orf55
|
chromosome 10 open reading frame 55 |
| chr20_+_58630972 | 1.30 |
ENST00000313426.1
|
C20orf197
|
chromosome 20 open reading frame 197 |
| chr14_-_21516590 | 1.29 |
ENST00000555026.1
|
NDRG2
|
NDRG family member 2 |
| chr21_+_34775181 | 1.27 |
ENST00000290219.6
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
| chr17_+_1665306 | 1.27 |
ENST00000571360.1
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chrX_-_131623874 | 1.26 |
ENST00000436215.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
| chr12_-_12491608 | 1.26 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
| chr5_-_137475071 | 1.26 |
ENST00000265191.2
|
NME5
|
NME/NM23 family member 5 |
| chr14_+_101299520 | 1.25 |
ENST00000455531.1
|
MEG3
|
maternally expressed 3 (non-protein coding) |
| chr4_-_83765613 | 1.24 |
ENST00000503937.1
|
SEC31A
|
SEC31 homolog A (S. cerevisiae) |
| chrX_-_131623982 | 1.23 |
ENST00000370844.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
| chr19_+_41497178 | 1.23 |
ENST00000324071.4
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
| chr6_-_30043539 | 1.23 |
ENST00000376751.3
ENST00000244360.6 |
RNF39
|
ring finger protein 39 |
| chr15_+_94899183 | 1.22 |
ENST00000557742.1
|
MCTP2
|
multiple C2 domains, transmembrane 2 |
| chr19_+_9203855 | 1.20 |
ENST00000429566.3
|
OR1M1
|
olfactory receptor, family 1, subfamily M, member 1 |
| chr13_-_33112899 | 1.18 |
ENST00000267068.3
ENST00000357505.6 ENST00000399396.3 |
N4BP2L2
|
NEDD4 binding protein 2-like 2 |
| chr12_+_101188718 | 1.18 |
ENST00000299222.9
ENST00000392977.3 |
ANO4
|
anoctamin 4 |
| chr3_-_42306248 | 1.17 |
ENST00000334681.5
|
CCK
|
cholecystokinin |
| chr4_-_100242549 | 1.15 |
ENST00000305046.8
ENST00000394887.3 |
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide |
| chr1_+_31769836 | 1.15 |
ENST00000344147.5
ENST00000373714.1 ENST00000546109.1 ENST00000422613.2 |
ZCCHC17
|
zinc finger, CCHC domain containing 17 |
| chr4_-_70725856 | 1.14 |
ENST00000226444.3
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1 |
| chr16_-_67881588 | 1.14 |
ENST00000561593.1
ENST00000565114.1 |
CENPT
|
centromere protein T |
| chr4_-_186732048 | 1.14 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr19_-_49496557 | 1.13 |
ENST00000323798.3
ENST00000541188.1 ENST00000544287.1 ENST00000540532.1 ENST00000263276.6 |
GYS1
|
glycogen synthase 1 (muscle) |
| chr1_+_78383813 | 1.12 |
ENST00000342754.5
|
NEXN
|
nexilin (F actin binding protein) |
| chr2_-_43453734 | 1.11 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
| chr5_-_160279207 | 1.10 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
| chr14_+_96722152 | 1.10 |
ENST00000216629.6
|
BDKRB1
|
bradykinin receptor B1 |
| chr12_-_56122124 | 1.07 |
ENST00000552754.1
|
CD63
|
CD63 molecule |
| chr6_+_150920999 | 1.06 |
ENST00000367328.1
ENST00000367326.1 |
PLEKHG1
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
| chr8_-_71157595 | 1.04 |
ENST00000519724.1
|
NCOA2
|
nuclear receptor coactivator 2 |
| chr11_-_33913708 | 1.03 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chr16_-_21436459 | 1.03 |
ENST00000448012.2
ENST00000504841.2 ENST00000419180.2 |
NPIPB3
|
nuclear pore complex interacting protein family, member B3 |
| chr6_+_31895254 | 1.03 |
ENST00000299367.5
ENST00000442278.2 |
C2
|
complement component 2 |
| chr9_+_99690592 | 1.02 |
ENST00000354649.3
|
NUTM2G
|
NUT family member 2G |
| chr6_-_133055896 | 0.99 |
ENST00000367927.5
ENST00000425515.2 ENST00000207771.3 ENST00000392393.3 ENST00000450865.2 ENST00000392394.2 |
VNN3
|
vanin 3 |
| chr1_+_174933899 | 0.99 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
| chr21_+_43619796 | 0.99 |
ENST00000398457.2
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
| chr3_+_136649311 | 0.96 |
ENST00000469404.1
ENST00000467911.1 |
NCK1
|
NCK adaptor protein 1 |
| chr14_+_32798462 | 0.95 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr2_-_198650037 | 0.95 |
ENST00000392296.4
|
BOLL
|
boule-like RNA-binding protein |
| chr5_-_39219705 | 0.94 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
| chr12_+_101188547 | 0.94 |
ENST00000546991.1
ENST00000392979.3 |
ANO4
|
anoctamin 4 |
| chrX_+_591524 | 0.94 |
ENST00000554971.1
ENST00000381575.1 |
SHOX
|
short stature homeobox |
| chr4_+_159593418 | 0.94 |
ENST00000507475.1
ENST00000307738.5 |
ETFDH
|
electron-transferring-flavoprotein dehydrogenase |
| chr4_-_52883786 | 0.94 |
ENST00000343457.3
|
LRRC66
|
leucine rich repeat containing 66 |
| chr19_+_852291 | 0.93 |
ENST00000263621.1
|
ELANE
|
elastase, neutrophil expressed |
| chrX_+_134166333 | 0.93 |
ENST00000257013.7
|
FAM127A
|
family with sequence similarity 127, member A |
| chr7_+_18535893 | 0.92 |
ENST00000432645.2
ENST00000441542.2 |
HDAC9
|
histone deacetylase 9 |
| chr6_-_32920794 | 0.92 |
ENST00000395305.3
ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
HLA-DMA
XXbac-BPG181M17.5
|
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
| chr1_+_209941827 | 0.92 |
ENST00000367023.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr1_+_61547894 | 0.91 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
| chr6_+_116832789 | 0.90 |
ENST00000368599.3
|
FAM26E
|
family with sequence similarity 26, member E |
| chr5_+_140602904 | 0.90 |
ENST00000515856.2
ENST00000239449.4 |
PCDHB14
|
protocadherin beta 14 |
| chr11_-_130786400 | 0.90 |
ENST00000265909.4
|
SNX19
|
sorting nexin 19 |
| chr6_+_130339710 | 0.90 |
ENST00000526087.1
ENST00000533560.1 ENST00000361794.2 |
L3MBTL3
|
l(3)mbt-like 3 (Drosophila) |
| chr11_-_1776176 | 0.90 |
ENST00000429746.1
|
CTSD
|
cathepsin D |
| chr1_+_207277590 | 0.90 |
ENST00000367070.3
|
C4BPA
|
complement component 4 binding protein, alpha |
| chr10_-_27444143 | 0.90 |
ENST00000477432.1
|
YME1L1
|
YME1-like 1 ATPase |
| chr12_-_79849240 | 0.89 |
ENST00000550268.1
|
RP1-78O14.1
|
RP1-78O14.1 |
| chr10_-_61900762 | 0.88 |
ENST00000355288.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr12_-_123215306 | 0.87 |
ENST00000356987.2
ENST00000436083.2 |
HCAR1
|
hydroxycarboxylic acid receptor 1 |
| chr18_-_59274139 | 0.86 |
ENST00000586949.1
|
RP11-879F14.2
|
RP11-879F14.2 |
| chr19_+_56652556 | 0.85 |
ENST00000337080.3
|
ZNF444
|
zinc finger protein 444 |
| chr2_-_31637560 | 0.83 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr6_+_47666275 | 0.83 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
| chrY_-_20935572 | 0.83 |
ENST00000382852.1
ENST00000344884.4 ENST00000304790.3 |
HSFY2
|
heat shock transcription factor, Y linked 2 |
| chr4_+_74301880 | 0.82 |
ENST00000395792.2
ENST00000226359.2 |
AFP
|
alpha-fetoprotein |
| chr1_-_186649543 | 0.82 |
ENST00000367468.5
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
| chr3_-_49726104 | 0.82 |
ENST00000383728.3
ENST00000545762.1 |
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
| chr10_+_114133773 | 0.82 |
ENST00000354655.4
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr1_+_152784447 | 0.81 |
ENST00000360090.3
|
LCE1B
|
late cornified envelope 1B |
| chr6_-_11779014 | 0.81 |
ENST00000229583.5
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
| chr5_-_124081008 | 0.81 |
ENST00000306315.5
|
ZNF608
|
zinc finger protein 608 |
| chr1_-_204183071 | 0.80 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
| chr10_+_103986085 | 0.80 |
ENST00000370005.3
|
ELOVL3
|
ELOVL fatty acid elongase 3 |
| chr7_-_17598506 | 0.80 |
ENST00000451792.1
|
AC017060.1
|
AC017060.1 |
| chr5_+_140782351 | 0.80 |
ENST00000573521.1
|
PCDHGA9
|
protocadherin gamma subfamily A, 9 |
| chr5_-_175965008 | 0.80 |
ENST00000537487.1
|
RNF44
|
ring finger protein 44 |
Network of associatons between targets according to the STRING database.
First level regulatory network of CEBPA
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 26.3 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 2.9 | 11.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 2.7 | 8.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 2.5 | 9.9 | GO:0035425 | autocrine signaling(GO:0035425) |
| 1.7 | 5.0 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.3 | 4.0 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 1.3 | 13.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
| 1.1 | 3.3 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.1 | 3.2 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
| 1.0 | 21.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.9 | 6.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.9 | 6.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.7 | 3.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
| 0.6 | 1.9 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.6 | 2.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.6 | 4.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.5 | 2.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.5 | 2.7 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.4 | 2.1 | GO:1903282 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.4 | 0.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.4 | 16.6 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.4 | 1.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.3 | 1.0 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.3 | 1.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 | 1.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.3 | 2.3 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 1.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.3 | 1.0 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.3 | 1.5 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.3 | 14.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.3 | 3.8 | GO:0015889 | cobalt ion transport(GO:0006824) cobalamin transport(GO:0015889) |
| 0.3 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 1.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.3 | 1.3 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 0.3 | 2.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.2 | 11.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.2 | 1.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 0.7 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.2 | 0.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.2 | 0.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 | 1.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.2 | 1.4 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.2 | 0.6 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 0.2 | 0.8 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
| 0.2 | 0.7 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 | 2.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 3.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 0.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.2 | 3.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 6.3 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.2 | 1.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 | 0.9 | GO:0018126 | protein hydroxylation(GO:0018126) peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.9 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 | 0.4 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.1 | 0.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 | 0.4 | GO:1904640 | response to methionine(GO:1904640) |
| 0.1 | 0.7 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 0.4 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 | 1.8 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 1.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 | 1.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 1.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 | 1.6 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 1.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 0.4 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.1 | 0.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.4 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.1 | 2.6 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 1.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.1 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.4 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.1 | 2.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 2.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.1 | 12.3 | GO:0050918 | positive chemotaxis(GO:0050918) |
| 0.1 | 0.5 | GO:0090294 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.1 | 1.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 1.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 1.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 0.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.1 | 1.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 0.3 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 | 0.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 | 0.6 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 1.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 1.1 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 | 3.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 | 0.5 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 | 0.3 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.1 | 0.5 | GO:0061364 | negative regulation of negative chemotaxis(GO:0050925) apoptotic process involved in luteolysis(GO:0061364) |
| 0.1 | 2.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 2.4 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 1.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 | 1.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 1.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 1.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.1 | 3.4 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.1 | 0.4 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.1 | 0.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 11.1 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 1.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.1 | 0.3 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 | 1.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 1.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.5 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 2.4 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 1.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 2.7 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.1 | 1.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 | 0.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.0 | 2.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.0 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.0 | 0.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.0 | 0.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.0 | 0.9 | GO:0072189 | ureter development(GO:0072189) |
| 0.0 | 0.2 | GO:0032525 | regulation of somitogenesis(GO:0014807) somite rostral/caudal axis specification(GO:0032525) |
| 0.0 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.0 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 | 0.2 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.0 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.0 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.0 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 | 0.1 | GO:2000724 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.0 | 0.1 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.0 | 0.4 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 | 1.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 | 0.2 | GO:0097319 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 | 0.2 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.0 | 1.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.0 | 3.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.4 | GO:0048863 | stem cell differentiation(GO:0048863) |
| 0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 | 0.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 1.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 | 1.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 1.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.2 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 | 1.4 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.3 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 0.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.0 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.6 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
| 0.0 | 0.6 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
| 0.0 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.0 | 2.0 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
| 0.0 | 1.3 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 0.2 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.0 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.8 | GO:0021884 | forebrain neuron development(GO:0021884) |
| 0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 1.4 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.4 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.0 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 | 0.2 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.0 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 0.1 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 1.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
| 0.0 | 0.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 | 0.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.1 | GO:0010810 | regulation of cell-substrate adhesion(GO:0010810) positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 | 1.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.9 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.0 | 0.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 15.9 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.6 | 28.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.5 | 50.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.3 | 7.8 | GO:0043203 | axon hillock(GO:0043203) |
| 0.3 | 1.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.3 | 4.3 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 16.9 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.2 | 1.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.2 | 31.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.2 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.1 | 1.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.1 | 1.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.6 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.1 | 1.8 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.1 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.1 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 3.2 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 1.7 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.1 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 1.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 1.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.1 | 0.2 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.1 | 6.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
| 0.1 | 1.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 3.0 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.0 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.0 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.0 | 1.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 1.0 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.0 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.0 | 7.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.0 | 0.9 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.0 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.8 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 0.2 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.0 | 3.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 1.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.0 | 1.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 3.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 33.2 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 4.3 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 2.0 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
| 0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.8 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 1.0 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.3 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.0 | 1.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.0 | 2.7 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 4.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.8 | GO:0005901 | caveola(GO:0005901) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.7 | 9.8 | GO:0089720 | caspase binding(GO:0089720) |
| 0.6 | 5.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.5 | 28.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.5 | 1.5 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.5 | 1.9 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.4 | 2.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.4 | 2.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.4 | 10.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.4 | 1.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.3 | 49.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 1.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 1.6 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.3 | 0.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 6.1 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 7.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.3 | 3.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.3 | 3.8 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.3 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
| 0.2 | 8.8 | GO:0001848 | complement binding(GO:0001848) |
| 0.2 | 1.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.2 | 0.6 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.2 | 1.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.2 | 1.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 1.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.2 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 0.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.2 | 1.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.2 | 2.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 0.5 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.2 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.2 | 0.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.1 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.1 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 1.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 1.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.1 | 25.6 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 1.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.1 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.1 | 4.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 1.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 1.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 0.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.1 | 1.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 1.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 7.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.1 | 0.3 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.1 | 2.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 3.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 1.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 1.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 4.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 2.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 17.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 1.5 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.2 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.1 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.1 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 2.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 2.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.0 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.0 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.0 | 0.2 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.0 | 1.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.0 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 2.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.0 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 1.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.7 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.0 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 0.0 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.0 | 0.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.0 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.0 | 2.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 0.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.0 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 1.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.0 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.0 | 1.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 3.7 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 6.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 10.2 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.0 | 0.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 1.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.0 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 1.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 18.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 14.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 11.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.2 | 66.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 5.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 2.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 11.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 2.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 3.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 2.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 3.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 2.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.0 | 2.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 7.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 1.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 5.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 1.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 28.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.7 | 11.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.6 | 18.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.4 | 9.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 5.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 3.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 6.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 3.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 15.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 2.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 2.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 4.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 2.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 4.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 4.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 1.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 2.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 0.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 1.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 2.6 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
| 0.0 | 3.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 1.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 1.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 1.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.0 | 1.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 2.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 1.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |